Desvenlafaxine

地文拉法辛

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameDesvenlafaxine
Drug Alias Name去甲文拉法辛DesvenlafaxinumDesvenlafaxinaKhedezlaDesvenlafaxine +[6] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin transporter inhibitorsNorepinephrine transporter inhibitors
TargetsNorepinephrine transporterSerotonin transporter
Therapy Area/IndicationsDepressive Disorder, MajorDepressive Disorder
Global Approved IndicationsDepressive Disorder, Major
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved Date2008/01/01
Country/TerritoryUnited StatesTaiwanChile +[7] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaPending
Originator CompaniesAlembic Ltd
China Registration ClassN/A

Develop Information

Active CompaniesAlembic Pharmaceuticals LtdAlembic LtdMochda Pharmaceutical Co Ltd
Inactive CompaniesWyeth LlcPfizer IncJiangsu Hansoh Pharmaceutical Group Co Ltd +[4] 
Active IndicationsDepressive Disorder, Major
Inactive IndicationsDepressive Disorder

Other Information

ATC CodeN06AX23
Related LinksWikipediaDrugBankKEGG